Yunu is serving life science companies and cancer centers to ignite collaboration and accelerate innovation.
Yunu’s aim is to ensure breakthrough therapies are accessible to everyone by unifying medical imaging insights and connecting clinical communities.
Yunu announces a major software release enabling pharma sponsors to configure studies in minutes, ensure imaging consistency, and deliver data directly to primary systems—while streamlining workflows for site staff.
Yunu, provider of transformative clinical trials imaging workflow solutions, secured an investment led by Spring Mountain Capital, affirming Yunu’s position as an emerging category leader and proven innovator within the clinical trial imaging market.
Cary, NC – – Yunu, a clinical trials imaging assessment workflow and data management platform, has opened access to their new Yunuverse for collaboration among pharma sponsors, trial sites, clinical research organizations (CROs), and on-demand clinician groups to transform the way imaging-based trials are conducted. Yunu is a fast-growing VC-backed SaaS eClinical solution ...
Yunu is pleased to announce its partnership with WCG, a global leader in clinical trial solutions, in support of WCG’s imaging services.
Join Yunu and City of Hope leaders for a candid discussion on the imaging challenges facing cancer centers today, and how technology driven strategies are reshaping oncology research, clinical workflows, and patient outcomes.
Yunu CTO Gael Kuhn shared, “With the infrastructure issue solved, imaging data is starting to come alive and transform research in remarkable ways. As Yunu continues to expand its footprint in the clinical trial landscape, a flywheel effect unlocks the full potential of imaging data in research.”